Page last updated: 2024-08-24

topotecan and Abnormalities, Autosome

topotecan has been researched along with Abnormalities, Autosome in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Glomme, S; Hertig, J; Hess, CF; Pradier, O; Rave-Fränk, M; Schmidberger, H; Virsik-Köpp, P; Weiss, E	1
Aydemir, N; Bilaloğlu, R	1
Beran, M; Estey, E; Giles, FJ; Kantarjian, HM; Keating, M; Koller, CA; Kornblau, S; O'Brien, SM	1

Trials

1 trial(s) available for topotecan and Abnormalities, Autosome

Article	Year
Results of topotecan single-agent therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leukemia & lymphoma, 1998, Volume: 31, Issue:5-6 Topics: Adult; Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Agents; Chromosome Aberrations; Genes, ras; Humans; Infusions, Intravenous; Karyotyping; Leukemia, Myelomonocytic, Chronic; Middle Aged; Remission Induction; Survival Analysis; Topotecan; Treatment Outcome	1998

Article

Year

Results of topotecan single-agent therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.

Leukemia & lymphoma, 1998, Volume: 31, Issue:5-6

Topics: Adult; Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Agents; Chromosome Aberrations; Genes, ras; Humans; Infusions, Intravenous; Karyotyping; Leukemia, Myelomonocytic, Chronic; Middle Aged; Remission Induction; Survival Analysis; Topotecan; Treatment Outcome

1998

Other Studies

2 other study(ies) available for topotecan and Abnormalities, Autosome

Article	Year
Combined effect of topotecan and irradiation on the survival and the induction of chromosome aberrations in vitro. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2002, Volume: 178, Issue:9 Topics: Adenocarcinoma; Antineoplastic Agents; Cell Line; Cell Survival; Chromosome Aberrations; Colonic Neoplasms; Fibroblasts; Glioblastoma; Humans; Lymphocytes; Metaphase; Neoplasms; Radiation Dosage; Radiation Tolerance; Radiation-Sensitizing Agents; Time Factors; Topotecan; Tumor Cells, Cultured	2002
Genotoxicity of two anticancer drugs, gemcitabine and topotecan, in mouse bone marrow in vivo. Mutation research, 2003, May-09, Volume: 537, Issue:1 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bone Marrow Cells; Chromosome Aberrations; Deoxycytidine; DNA Damage; Dose-Response Relationship, Drug; Gemcitabine; Mice; Micronucleus Tests; Mitosis; Regression Analysis; Time Factors; Topotecan	2003

Article

Year

Combined effect of topotecan and irradiation on the survival and the induction of chromosome aberrations in vitro.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2002, Volume: 178, Issue:9

Topics: Adenocarcinoma; Antineoplastic Agents; Cell Line; Cell Survival; Chromosome Aberrations; Colonic Neoplasms; Fibroblasts; Glioblastoma; Humans; Lymphocytes; Metaphase; Neoplasms; Radiation Dosage; Radiation Tolerance; Radiation-Sensitizing Agents; Time Factors; Topotecan; Tumor Cells, Cultured

2002

Genotoxicity of two anticancer drugs, gemcitabine and topotecan, in mouse bone marrow in vivo.

Mutation research, 2003, May-09, Volume: 537, Issue:1

Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bone Marrow Cells; Chromosome Aberrations; Deoxycytidine; DNA Damage; Dose-Response Relationship, Drug; Gemcitabine; Mice; Micronucleus Tests; Mitosis; Regression Analysis; Time Factors; Topotecan

2003